Stockscreener 앱 받기
0.6357
26.24%
-0.2262
시간 외 거래:
.63
-0.0057
-0.90%
전일 마감가:
$0.8619
열려 있는:
$1.12
하루 거래량:
56.87M
Relative Volume:
22.27
시가총액:
$3.35M
수익:
$12.99M
순이익/손실:
$-23.72M
주가수익비율:
-0.00654
EPS:
-97.2514
순현금흐름:
$-23.28M
1주 성능:
-38.88%
1개월 성능:
-75.26%
6개월 성능:
-92.81%
1년 성능:
-97.64%
1일 변동 폭
$0.6036
$1.35
1주일 범위
$0.6036
$1.35
52주 변동 폭
$0.6036
$51.06
Aptevo Therapeutics Inc Stock (APVO) Company Profile
명칭
Aptevo Therapeutics Inc
전화
206-838-0500
주소
2401 4TH AVE., SEATTLE, WA
APVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
0.6357 | 3.35M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-11-05 | 개시 | Ladenburg Thalmann | Buy |
| 2017-10-05 | 재개 | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc 주식(APVO)의 최신 뉴스
Aptevo Therapeutics (APVO) Secures $2M Through Registered Direct Offering | APVO Stock News - GuruFocus
Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | APVO Stock News - GuruFocus
Aptevo Therapeutics announces $2 million stock offering - Investing.com
Aptevo Therapeutics Raises Fresh Capital: $2M Boost for Revolutionary Cancer Treatment Development - Stock Titan
Aptevo Therapeutics Inc (APVO) Stock: Navigating a Year of Volatility - investchronicle.com
How does APVO’s price to cash per share ratio compare in the market? - uspostnews.com
Aptevo Therapeutics (APVO) Completes $2.1 Million Stock Offering - GuruFocus
Why Netflix Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
APVO stock plunges to 52-week low, touches $0.94 By Investing.com - Investing.com South Africa
APVO stock plunges to 52-week low, touches $0.94 - Investing.com Australia
Alligator Bioscience and Aptevo Therapeutics to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types at ESMO Congress 2024 - ACCESS Newswire
Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High - Asianet Newsable
Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Aptevo Secures Fresh $2.1M Capital: What This Means for Clinical Pipeline - Stock Titan
SEC Form 424B4 filed by Aptevo Therapeutics Inc. - Quantisnow
Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize
Aptevo (APVO) Sees Significant Market Rally After Equity Offering - Stocks Telegraph
11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aptevo Therapeutics Launches $2.1 Million Registered Direct Offering; Shares Rise - MarketScreener
Aptevo Therapeutics (APVO) Announces $2.1 Million Securities Off - GuruFocus
Aptevo Therapeutics announces registered direct offering and warrants sale - Investing.com
Aptevo Therapeutics prices 1.76M shares at $1.19 in registered direct offering - TipRanks
Aptevo Raises Fresh Capital: $2.1M Direct Offering Plus Warrant Restructuring - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan - ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Press Release Distribution & PR Platform - ACCESS Newswire
APVO stock plunges to 52-week low, touches $0.99 By Investing.com - Investing.com India
APVO stock plunges to 52-week low, touches $0.99 - Investing.com
Virtu Financial LLC Has $93,000 Stake in Aptevo Therapeutics Inc. (NASDAQ:APVO) - Defense World
Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Significant Growth in Short Interest - Defense World
APVO stock plunges to 52-week low, touches $2.32 - Investing.com India
APVO stock plunges to 52-week low, touches $2.32 By Investing.com - Investing.com UK
Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment - Benzinga
Aptevo Therapeutics Reports 2 More Remissions in AML Trial -March 20, 2025 at 09:35 am EDT - Marketscreener.com
Aptevo Therapeutics Achieves Remission Success in AML Trial - TipRanks
Aptevo reports two additional AML patients achieve remission in RAINIER trial - TipRanks
Breakthrough: New AML Drug Shows 90% Success Rate, Outperforming Standard Therapy by 24% - StockTitan
Aptevo Therapeutics advances cancer antibody APVO603 in preclinical phase - Investing.com
Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy - ACCESS Newswire
Breakthrough Cancer Drug APVO603 Targets Two Immune Pathways to Fight Solid Tumors - Stock Titan
Aptevo Therapeutics (NASDAQ:APVO) Raised to Sell at StockNews.com - Defense World
Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Significant Increase in Short Interest - Defense World
APVO stock plunges to 52-week low of $2.48 amid steep annual decline - Investing.com Australia
APVO stock plunges to 52-week low of $2.48 amid steep annual decline By Investing.com - Investing.com South Africa
Aptevo Therapeutics Inc (APVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
4.32%
자본화:
|
볼륨(24시간):